Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00794586
Recruitment Status : Completed
First Posted : November 20, 2008
Last Update Posted : December 27, 2013
Information provided by (Responsible Party):
Gilead Sciences

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 2010
Actual Study Completion Date : March 2010
Certification/Extension First Submitted : December 3, 2013